ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 185 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $162,000 | +189.3% | 13,088 | +220.2% | 0.01% | +150.0% |
| Q3 2016 | $56,000 | +47.4% | 4,088 | -19.9% | 0.00% | +100.0% |
| Q2 2016 | $38,000 | +15.2% | 5,103 | -1.2% | 0.00% | 0.0% |
| Q1 2016 | $33,000 | +266.7% | 5,165 | +256.2% | 0.00% | – |
| Q4 2015 | $9,000 | +12.5% | 1,450 | +7.4% | 0.00% | -100.0% |
| Q3 2015 | $8,000 | -52.9% | 1,350 | -35.7% | 0.00% | 0.0% |
| Q2 2015 | $17,000 | 0.0% | 2,100 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $17,000 | +88.9% | 2,100 | +55.6% | 0.00% | 0.0% |
| Q4 2014 | $9,000 | +350.0% | 1,350 | +285.7% | 0.00% | – |
| Q3 2014 | $2,000 | 0.0% | 350 | 0.0% | 0.00% | – |
| Q2 2014 | $2,000 | -80.0% | 350 | -73.1% | 0.00% | -100.0% |
| Q1 2014 | $10,000 | – | 1,300 | +64900.0% | 0.00% | – |
| Q4 2013 | $0 | -100.0% | 2 | -99.6% | 0.00% | -100.0% |
| Q3 2013 | $9,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $9,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |